Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, it is not Xi.
Xi is the latest 4th generation which is in the market already.
I can send you the photo I took.
Dont know yet. The technician refused to confirm price.
Not too many changes on the workstation, but the patient cart is completely different.
Tried simple manipulations, rings, etc. Took a few photos, and then introductions on the end effectors.
I anticipated Da Vinci's product preview session yesterday, saw their 5th generation robot in person. Same single incision but with 4 arms (1 for camera, 3 snake arms). Technician told me the 2nd batch is under production but the whole product with accessories have not yet launched.
So Titan needs to be quick.
Aye, aye
I will be more than happy to take the noble tile of 'nigerian prince' as granted today.
Well spotted buddy
You will be rewarded with 1M USD if you wire 100USD to my butler's bank account so that my throne can be secured.
I said two days ago, PPS will stay below 0.44, no one believe.
Same day, I said major selling force hasn't come out yet, no one believe.
I said yesterday, PPS will continue to drop, still no one believe.
Today I said, the function of SPORTS is limited and Titan needs funding urgently, again, no one believe.
Now I am saying, those surgeons who led the investment will exit when they can. Will you believe?
Here, I can tell you in advance why:
Many people may find it is a good news that those surgeon did not ask for the warrant. It is not common at all. But if you look at the PPS at that time, they got big discount on the negotiated price. So this is the 1st reason why no warrant came with the placement.
2nd, they are not very optimistic on the machine, and they are using their own money to invest. So they are very careful and very smart. They exchanged their warrant rights with a much lower investment price, just want to make considerable amount of money when the time comes, but not looking at further investments through pre-secured warrants.
Therefore, those surgeons are short-term players too, and they will exit when their investment returns are met, a one-time clean investment.
you can keep this and see if they perform in this way in the future.
hahaha, please, no silly talks if you are not a surgeon who knows Da vinci and had hand-on sessions on SPORTS.
As far as I know, the active operation space in side the body for Titan is quite limited when comparing with Intuitive.
And, titian is mainly focus on hypogastrium area, anocelia and any other area beyond are just planning.
So it is a machine with quite limted functions at a much lower price than Intuitive, but with the unique snake arm, which Intuitive was researching two years ago and now is design freezed but not yet launched to the market.
It will be a tremendous news to know that Titan has enough funding for 2018.
Please let me know when this kind of news comes out.
I will purchase more shares than I ever have to show my support.
Thank you.
From my calculation based on Titan's released report, what Mc said enough fundings for this year is correct, and it is really JUST enough for this year. Only 1-2M USD left at most for 2018. Do you really think Mc plans to keep a low-profile? Keeping an optimistic view at the best he could be to show to the market is what he has always been doing. So I personally believe what he said is really what it is.
Also, I personally do not think Longtai will exercise their warrants.
As Longtai is a long-term investor (a 'previous' business partner to Titan), I think they must be very smart. If they do have money and willing to help Titan, they would prefer negotiating a private placement with Titan.
1. For new shares and warrants
2. Better news for Titan to publish
So no reason for Longtai to exercise warrants, unless when they prefer to exit.
I suggest to you buddy, when Longtai exercise their warrants, it will be the time for us all to run for exiting as fast as we can.
I do agree with you buddy.
I personally have been monitoring TITXF for a long long time, and started to establish my play when the PPS was just below 0.2.
As Titan mentioned a few months ago, testings in three medical centres are the all essential and major operations needed for the FDA. However, in order to complete the software and training stuffs, they require min. 19.5M USD for the Q1 &Q2 in 2018, which are realistic but urgent issues.
According to Mc announced a few days ago, the current funding is sufficient for 2017, which in another word, money for 2018 is still in the air. If Mc has prepared sufficient funding to support the first few months of 2018, he definitely would have mentioned not just 2017, but 2018, or at least the beginning of 2018, to show more confidence to the market.
The reasons for the PPS increase from 0.9 to 0.49 in such short period of time are mainly the surgeon led investments, news from florida&Columbia PLUS warrant exercise. These news shows that Titan got enough funding for now and is just right on the scheduled milestones.
However, the warrant exercise always causes PPS drop for companies like Titan as the only reason for exercising warrant is to realise the investment return, especially large new share volume like this. And investors have and more investors will realise that titan can live for this year but no secured funding for next year, while 2018 requires extremely large funding.
There is just 1.5 month left before the Christmas holiday, if Titan fail to come up with a funding plan before the end of this year, 2018 milestone and PPS (and further warrant exercise in the future) are all in danger, regardless how many good news Titan can release.
yes, my advisor told me that I have completely brainwashed by myself to believe in TITXF.
I am now on a bet with him. If I get 200% profit from TITXF within two years, his whole year base salary will be mine. Otherwise, I will pay him that amount.
Exactly.
Definitely not retail investors. They are companies and institutes who previously invested at 0.2level and now running away from Titan to realise their investment return.
These short-term investors do no good to Titan, as they will hurt Titan in long-term. Also, Titan is over drafting its reputation to welcome these short-term investors, as these investors will never go for the company's development. They may boost the short-term market confidence by providing limited funding to the company. But as they just aim for the short-term investment return, hey will flee as soon as their targets are met. When such things happen for multiple times, fewer investment companies will come.
Of course not me, otherwise, Mc would have contacted me for holding shares without selling them and asking me to invest more, hahaha
Any investment company which enters Titan at the current PPS level is actually paying for the previous companies' investment return. The only temptation is the private offering price, what else? the FDA is at least 1.5 yrs away! Bearing the risk of not meeting the 2018 milestones, risk of postpone FDA application, risk of sales, risk of company's insufficient funding, etc...
When investment companies can make easy and secured money at the pre-FDA level, why do they risk this much at the current stage? When They can enter at the pre-FDA stage and make easy 200% return, any reason for them to risk for the possibility of 500% return?
So I presume Mc is working on it, but very difficult. I have invested as much as I could, and of course I want Titan to be rocket high, but who knows in the future
I personally do agree with your point. Only the floor price may not drop to 0.1 USD, probably will be above 0.2 USD, as Mc is achieving current milestones as scheduled, with sufficient money in the account for this year's operation.
Unless the design for the mass-manufacturing is finalized or further FDA certificate is obtained, any more developmental news will not make huge positive impact to the capital market.
Or, if Mc secures the funding for the company's 2018 Q1&Q2 operation (20M USD min. in R&D!! Monthly operation cost does NOT included yet! I guess 30M USD is required to complete the Q1&Q2, only if no unexpected spending occur.), the incoming funding news will generate a much greater positive impact to the capital market.
5M volume / 2M USD yesterday.
Still have 4M USD shares waiting to be sold to realize the investment return from the exercised warrants.
Unless Mc asks investment companies to hold from selling shares or the development news come out, further drop will occur today.
With warrants exercise on the way, only 65-70M shares need to be issued? Hold on a sec, let me work on some math for you buddy.
The average market cap for TransEnterix is 420M USD, with FDA and CE certificate and European installation of 7 units.
Lets assume titan obtains both FDA and CE certificate at the beginning of 2019, achieve sales around mid 2019, with the consideration of unique advantage of snake arm, the initial market cap for Titan after the completion of commercialization is 150% of TransEnterix (which is 420M as mentioned), makes Titan Medical with the market cap of 630M USD. So 630M USD is our realistic target for the company's market cap in 2019.
The current total number of shares for titan is 290M, if all warrants (all profitable warrants at the current price level) are exercised, it will become 350M. If the PPS continue to increase to 0.8USD with 50M new shares issued (with another 50M new warrants issued) and 3200 profitable warrants exercised, the total number of shares will be 432M. What can be expected is Titan still need to issue 20M new shares to reach commercialization. This 20M new shares come with 20M new warrants, the total number of shares will boost to 472M.
Now, take previous calculated 630M USD market cap into account, the PPS will be 1.33USD.
If we consider TransEnterix that its PPS tripled when passed FDA, 0.44USD is the fair 'benchmark' pps for titan at the current stage.
All above figures are calculated under the best scenario. so total new shares issued will be at least 70M shares PLUS 70million warrants only when ALL current profitable warrants are exercised!
Hey EIT, you really think 40million volume consist most of the new share sells? The major selling force hasn't come out yet!
Just look at today, it is the spearhead force, not yet the principle force.
So we need more news, more solid news. Otherwise, it will be fairly common to see the PPS stays below 0.44
Dont forget that the only reason for investors to exercise warrants is to sell new shares to exit and realize their investment return. Otherwise, they would hold their warrants for a few years (before the 60months deadline). Investors are not philanthropists to help company, their only primary objective is investment return.
Also, Investors usually sell their existing shares before exercising warrants, so that they can use cash from share selling to invest in exercising warrants.
Therefore, if we rely on warrant execution only, the cash generated may not be enough. (More shares to be sold, more warrants to be exercised, much lower PPS) Also, Florida hospital has given good news on the product, so what can be expected is the news from Columbia should be also not bad, same with IHU. As these results can all be expected now, the positive influence to the capital market (on the PPS) is very limited.
Relying on warrants only works in math, not in reality.
A shell company... Possibly... Never heard this company before, probably just like what they said, a specialised company with markets in Asia Pacific only.
Since Longtai is the biggest shareholder, I personally expect Longtai continue to invest and help Titan now. Maybe another 8M or 10M will make Titan live a much easier life for next year... Same thing, fantastic if there is any other company who is able to provide large fund injection to help Titan in meeting the 2018 milestones.
As long as Titan can continue to meet the milestones and the PPS increases (necessary drops occasionally) all the way to the FDA stage, I wouldn't mind to see any changes.
Though Mc said the current cash in hand is enough for the company's operation for the rest of this year, the necessary cash preparations to accomplish the 2018 milestones (especially min. 20M for the Q1&Q2) are definitely at the top of the company's objective list for now.
e.g. No doubt that you will have a good Christmas, only when you have (or certainly will have) enough money in hand to support your family after the Christmas. (You never expect this Christmas to be your last Christmas in life, do you?)
Since the Christmas holiday is approaching in about 1.5months' time, the clock is ticking for Mc to secure the Titan's next year operation NOW!